PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Reported to reduce serum glucose levels in diabetic patients [PMID: 30643523]; review of Andean crops suggests possible hypoglycemic effects through enzymatic inhibition in vitro and glucose reduction in preclinical and clinical trials [PMID: 38597476].
Extract decreased adhesion of uropathogenic E. coli to bladder epithelial cells in vitro [PMID: 30643523].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 27638916 (2016) — Lost crops of the Incas: Origins of domestication of the Andean pulse crop tarwi, Lupinus mutabilis. · American journal of botany
- 2.PMID: 38271901 (2024) — Flavonoid diversity in bitter and debittered seeds of Andean lupin (Lupinus mutabilis Sweet). · Food chemistry
- 3.PMID: 35270124 (2022) — Available Strategies for the Management of Andean Lupin Anthracnose. · Plants (Basel, Switzerland)
- 4.PMID: 37174379 (2023) — Isoflavone Content and Nutritional-Related Properties of Debittered Seeds from Two Andean Lupin (Lupinus mutabilis Sweet) Ecotypes Propagated in Two Soils. · Foods (Basel, Switzerland)
- 5.PMID: 33523360 (2021) — Chemical Composition, Tocopherol and Carotenoid Content of Seeds from Different Andean Lupin (Lupinus mutabilis) Ecotypes.